Financial Advisors Network’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.63M Buy
20,789
+845
+4% +$66.1K 0.25% 62
2025
Q1
$1.45M Buy
19,944
+355
+2% +$25.7K 0.24% 63
2024
Q4
$1.45M Buy
+19,589
New +$1.45M 0.24% 61
2023
Q4
$1.23M Hold
16,148
0.25% 54
2023
Q3
$1.12M Buy
+16,148
New +$1.12M 0.25% 52
2022
Q4
$1.17M Buy
15,721
+2,847
+22% +$212K 0.31% 49
2022
Q3
$1.06M Buy
12,874
+157
+1% +$13K 0.31% 48
2022
Q2
$1.21M Sell
12,717
-84
-0.7% -$7.99K 0.34% 47
2022
Q1
$1.51M Sell
12,801
-426
-3% -$50.2K 0.37% 45
2021
Q4
$1.71M Buy
13,227
+1,133
+9% +$147K 0.39% 46
2021
Q3
$1.4M Sell
12,094
-35
-0.3% -$4.06K 0.32% 48
2021
Q2
$1.26M Sell
12,129
-302
-2% -$31.3K 0.37% 48
2021
Q1
$1.04M Hold
12,431
0.34% 51
2020
Q4
$1.13M Hold
12,431
0.39% 45
2020
Q3
$992K Hold
12,431
0.39% 45
2020
Q2
$859K Buy
12,431
+1,196
+11% +$82.6K 0.35% 47
2020
Q1
$706K Hold
11,235
0.34% 47
2019
Q4
$874K Hold
11,235
0.4% 48
2019
Q3
$824K Hold
11,235
0.42% 46
2019
Q2
$798K Hold
11,235
0.43% 45
2019
Q1
$639K Sell
11,235
-270
-2% -$15.4K 0.37% 52
2018
Q4
$587K Buy
+11,505
New +$587K 0.37% 57
2018
Q2
$551K Buy
+11,355
New +$551K 0.33% 57
2017
Q4
$448K Buy
11,934
+24
+0.2% +$901 0.3% 68
2017
Q3
$434K Hold
11,910
0.34% 57
2017
Q2
$469K Buy
+11,910
New +$469K 0.39% 49
2017
Q1
Sell
-78
Closed -$2.51K 207
2016
Q4
$2.51K Buy
+78
New +$2.51K ﹤0.01% 412